Detalhe da pesquisa
1.
A partial epithelial-mesenchymal transition signature for highly aggressive colorectal cancer cells that survive under nutrient restriction.
J Pathol
; 262(3): 347-361, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38235615
2.
ATF2 loss promotes 5-FU resistance in colon cancer cells via activation of the ATR-Chk1 damage response pathway.
BMC Cancer
; 23(1): 480, 2023 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37237279
3.
ATF2 loss promotes tumor invasion in colorectal cancer cells via upregulation of cancer driver TROP2.
Cell Mol Life Sci
; 79(8): 423, 2022 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35838828
4.
Roflumilast inhibits tumor growth and migration in STK11/LKB1 deficient pancreatic cancer.
Cell Death Discov
; 10(1): 124, 2024 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38461159
5.
A Gene Signature Derived from the Loss of CDKN1A (p21) Is Associated with CMS4 Colorectal Cancer.
Cancers (Basel)
; 14(1)2021 Dec 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35008299
6.
EMT transcription factor ZEB1 alters the epigenetic landscape of colorectal cancer cells.
Cell Death Dis
; 11(2): 147, 2020 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32094334
7.
DAPK1 loss triggers tumor invasion in colorectal tumor cells.
Cell Death Dis
; 10(12): 895, 2019 11 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31772156